Cite
MLA Citation
Marco Caminati et al.. “Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response.” Expert review of respiratory medicine, vol. 13, 2019, pp. 1205–1212. http://access.bl.uk/ark:/81055/vdc_100095332638.0x00000c